does glp 1 damage kidneys GLP-1 agonists in the treatment of chronic kidney disease in type 2 diabetes and obesity Design and discovery of a

Described as the first selective GHRP-receptor agonist. Bone Biology 1999 Bone-growth dissociated from IGF-1 (15-day rat model) Johansen and colleagues reported dose-dependent increases in longitudinal bone-growth rate in adult female rats after 15 days of ipamorelin administration, with total IGF-I and IGFBPs unchanged a dissociation of skeletal effects from the sustained IGF-1 axis in this short-duration preclinical model

Higher absorption rate The intramuscular injection method ensures a 95% absorption rate compared to oral supplements, which have only 50% absorption

The lifespan of the treated mice increased by 10 to 12 per cent compared with a control group that received no supplement, and the treated worms also lived longer

Study populations, study design and baseline HbA1c varied between the studies